Jump to main content
文書・図像類

消化器癌の悪性化機序を促進する炎症性因子の同定と制御に関する基礎的・臨床的研究

Icons representing 文書・図像類

消化器癌の悪性化機序を促進する炎症性因子の同定と制御に関する基礎的・臨床的研究

Material type
文書・図像類
Author
上野, 真一
Publisher
鹿児島大学
Publication date
-
Material Format
Digital
Capacity, size, etc.
-
NDC
-
View All

Notes on use

Note (General):

2011-2013年度科学研究費助成事業(基盤研究(C))研究成果報告書 課題番号:23591992 研究代表者:上野真一(鹿児島大学・医歯(薬)学総合研究科・特任教授)炎症遷延化を引き起こすHMGB1と呼応するTLR-4、マクロファージ/TAMの動態、またEMTの存在について、ヒト肝癌(HCC)を...

Search by Bookstore

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

  • Kagoshima University Repository

    Digital
    You can check the holdings of institutions and databases with which Institutional Repositories DataBase(IRDB)(Institutional Repository) is linked at the site of Institutional Repositories DataBase(IRDB)(Institutional Repository).

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
文書・図像類
Author/Editor
上野, 真一
Author Heading
Publication, Distribution, etc.
Alternative Title
Basic and clinical sudies regarding to the idenification of inflammatory factors promoting the malignant transformation mechanism in digestive organ cancer
Text Language Code
jpn
Target Audience
一般
Note (General)
2011-2013年度科学研究費助成事業(基盤研究(C))研究成果報告書 課題番号:23591992 研究代表者:上野真一(鹿児島大学・医歯(薬)学総合研究科・特任教授)
炎症遷延化を引き起こすHMGB1と呼応するTLR-4、マクロファージ/TAMの動態、またEMTの存在について、ヒト肝癌(HCC)を用いて検討し、TAMに対する独自の抗FRβイムノトキシンによる制御を検討した。HMGB1レベルとTAM数、またTAM数と予後の相関がみられた。EMTに関する知見では、転写因子ZEB-1も関与した。一方、TAMの制御に関して、抗FRβイムノトキシンをヌードマウスHepG2皮下移植モデルに投与したところ、著明な腫瘍増殖抑制効果が認められた。以上の結果より、組織HMGB1とこれらにより誘導されるTAMによる腫瘍組織悪性化(形質転換)への可能性の関連が強く示唆された。
To investigate the cancer transformation of human hepatocellular carcinoma (HCC), the change of HMGB1 and its receptor TLR-4 with tissue macrophage (TAM) were analyzed. Moreover, the usefulness of FrB immunotoxin against TAM was studied if it could diminish tumor's malignant transformation. In HCC, correlations of HMGB1 level and number of TAM, and the number of TAM and patients prognosis were seen. For the knowledge about EMT, transcription factor ZEB-1 participated, too. On the other hand, after giving FrB immunotoxin to nude mouse HepG2 transplant model under skin, a clear effect of tumor promotion was seen. With these considerations, it was suggested that HMGB1 and derived TAM would contribute to the malignant transformation of HCCs, and FrB immunotoxin could be a treatment strategy.